These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25522999)

  • 1. HDL in infectious diseases and sepsis.
    Pirillo A; Catapano AL; Norata GD
    Handb Exp Pharmacol; 2015; 224():483-508. PubMed ID: 25522999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipoproteins are important components of the immune system.
    Han R
    Microbiol Immunol; 2010 Apr; 54(4):246-53. PubMed ID: 20377753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications.
    Wu A; Hinds CJ; Thiemermann C
    Shock; 2004 Mar; 21(3):210-21. PubMed ID: 14770033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective role of high density lipoproteins in sepsis: basic issues and clinical implications].
    Contreras-Duarte S; Varas P; Awad F; Busso D; Rigotti A
    Rev Chilena Infectol; 2014 Feb; 31(1):34-43. PubMed ID: 24740772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
    Maïga SF; Kalopissis AD; Chabert M
    Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia inducible factor (HIF) function in innate immunity and infection.
    Zinkernagel AS; Johnson RS; Nizet V
    J Mol Med (Berl); 2007 Dec; 85(12):1339-46. PubMed ID: 18030436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting high-density lipoproteins: update on a promising therapy.
    Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
    Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL in innate and adaptive immunity.
    Catapano AL; Pirillo A; Bonacina F; Norata GD
    Cardiovasc Res; 2014 Aug; 103(3):372-83. PubMed ID: 24935428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoproteins modulate the inflammatory response to lipopolysaccharide.
    Berbée JF; Havekes LM; Rensen PC
    J Endotoxin Res; 2005; 11(2):97-103. PubMed ID: 15949136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum amyloid protein A (SAA) and HDL. Clinical implication and surgical resuscitation].
    Bienvenu J; Deshaires P; Bernon H; Armanet P; Peristeris P; Lepape A; Perdrix JP
    Ann Biol Clin (Paris); 1988; 46(5):343-6. PubMed ID: 3138928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
    Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C
    Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.
    Shepherd J; Packard CJ; Patsch JR; Gotto AM; Taunton OD
    J Clin Invest; 1979 May; 63(5):858-67. PubMed ID: 221531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid bodies in innate immune response to bacterial and parasite infections.
    D'Avila H; Maya-Monteiro CM; Bozza PT
    Int Immunopharmacol; 2008 Oct; 8(10):1308-15. PubMed ID: 18687292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Density Lipoproteins Are Bug Scavengers.
    Meilhac O; Tanaka S; Couret D
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32290632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoproteins during sepsis: from bench to bedside.
    Tanaka S; Couret D; Tran-Dinh A; Duranteau J; Montravers P; Schwendeman A; Meilhac O
    Crit Care; 2020 Apr; 24(1):134. PubMed ID: 32264946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.